For the quarter ending 2026-03-31, CGABL had -$290,900K decrease in cash & cash equivalents over the period. -$1,270,500K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income (loss) | -141,900 | 345,500 | 112,500 | 486,700 |
| Depreciation and amortization | 50,500 | 49,000 | 48,500 | 94,600 |
| Equity-based compensation | 119,800 | 87,600 | 90,700 | 196,400 |
| Non-cash performance allocations and incentive fees, net | -283,100 | 291,600 | -263,700 | 250,600 |
| Non-cash principal investment (income) loss | 39,600 | -144,000 | 82,800 | -32,600 |
| Other non-cash amounts | 2,100 | 2,000 | 900 | -36,800 |
| Realized/unrealized (gain) loss on investments of consolidated funds | -248,600 | -83,600 | 88,500 | 11,600 |
| Realized/unrealized (gain) loss from loans payable of consolidated funds | 184,200 | 25,500 | 34,700 | 41,300 |
| Purchases of investments by consolidated funds | 4,092,800 | 2,710,100 | 4,957,100 | 4,033,200 |
| Proceeds from sales and settlements of investments by consolidated funds | 2,199,800 | 1,244,100 | 2,858,200 | 2,311,100 |
| Non-cash interest income, net | 4,200 | 16,200 | 4,300 | 8,700 |
| Change in cash and cash equivalents held at consolidated funds | -169,000 | 197,800 | 88,300 | -405,400 |
| Change in other receivables held at consolidated funds | 143,600 | -58,200 | 18,500 | -10,500 |
| Change in other liabilities held at consolidated funds | 606,600 | 105,400 | 79,300 | -14,000 |
| Purchases of investments | 148,200 | 152,500 | 106,800 | 144,300 |
| Proceeds from the sale of investments | 160,800 | 168,900 | 194,400 | 469,600 |
| Payments of contingent consideration | 0 | 0 | 1,700 | 1,000 |
| Changes in deferred taxes, net | 45,400 | -37,700 | 51,000 | 16,500 |
| Change in due from affiliates and other receivables | 1,700 | -53,400 | -7,600 | 16,300 |
| Change in deposits and other | -7,100 | 15,600 | 500 | 24,900 |
| Change in accounts payable, accrued expenses and other liabilities | -66,100 | 111,900 | -1,300 | 39,100 |
| Change in accrued compensation and benefits | -461,200 | 156,500 | 54,800 | -116,200 |
| Change in due to affiliates | 18,000 | 1,900 | 1,500 | 23,600 |
| Change in lease right-of-use assets and lease liabilities | -4,500 | -700 | -3,400 | -6,300 |
| Change in deferred revenue | 229,800 | -243,200 | 169,100 | 57,600 |
| Net cash used in operating activities | -1,242,400 | -1,195,100 | -1,559,500 | -520,900 |
| Purchases of corporate treasury investments | - | 0 | 0 | 0 |
| Proceeds from corporate treasury investments | - | 0 | 0 | - |
| Purchases of fixed assets, net | 28,100 | 42,000 | 23,200 | 34,200 |
| Net cash used in investing activities | -28,100 | -42,000 | -23,200 | -34,200 |
| Borrowings under credit facilities | - | 0 | 0 | 0 |
| Repayments under credit facilities | - | 0 | 0 | 0 |
| Issuance of 5.050 senior notes due 2035, net of financing costs | - | 2,000 | 792,900 | - |
| Payments on clo borrowings | 22,500 | 4,500 | 11,900 | 40,100 |
| Proceeds from clo borrowings, net of financing costs | 32,400 | 25,200 | 49,700 | 15,100 |
| Net borrowings on loans payable of consolidated funds | 579,800 | 1,257,400 | 1,700,000 | 1,055,100 |
| Dividends to common stockholders | 126,400 | 125,900 | 126,500 | 252,700 |
| Payment of deferred consideration for carlyle holdings units | - | 0 | 0 | 0 |
| Contributions from non-controlling interest holders | 783,900 | 112,600 | 367,800 | 231,300 |
| Distributions to non-controlling interest holders | 89,800 | 32,700 | 109,700 | 198,400 |
| Common shares repurchased and net share settlement of equity-based awards | 204,800 | 203,700 | 202,700 | 280,100 |
| Change in due to/from affiliates financing activities | -35,700 | 55,400 | -29,000 | 3,400 |
| Net cash provided by financing activities | 988,300 | 975,000 | 2,488,600 | 526,800 |
| Effect of foreign exchange rate changes | -8,700 | 9,300 | 43,600 | 38,700 |
| Decrease in cash, cash equivalents and restricted cash | -290,900 | -252,800 | 949,500 | 10,400 |
| Cash, cash equivalents and restricted cash, beginning of period | 1,973,600 | 2,226,400 | 1,266,500 | - |
| Cash, cash equivalents and restricted cash, end of period | 1,682,700 | 1,973,600 | 2,226,400 | - |
Carlyle Group Inc. (CGABL)
Carlyle Group Inc. (CGABL)